 region chemotherapi continu intraves infus doxorubicin treatment muscl invas transit cell bladder carcinoma rat model anim model invas transit cell bladder carcinoma continu infus intraves drug deliveri urotheli toxic antineoplast efficaci continu intraves infus doxorubicin dox dose-respons toxic experi histolog chang rat urinari bladder urotheli exposur differ urinari level dox function durat drug infus system local drug absorpt dox level serum bladder lymph node interv drug administr vitro chemosensit assay tumor sensit dox treatment studi impact continu infus dox day tumor implant discern chang normal urothelium bladder anim continu intravesicl dox mean urinari concentr micrograms./ml micrograms./ml micrograms./ml period day serum drug concentr non-signific upward trend start therapi signific increas tissu dox level bladder lymph node chemotherapi day mean tissu dox concentr bladder lymph node vitro sensit dox-treat tumor-bear anim mean tumor volum standard deviat gm gm averag tumor volum gm gm control group continu infus intralumin chemotherapi clear cytoreduct effect minim local toxic model drug tissu level region lymphat drainag field bladder wall further studi approach bladder-spar altern invas diseas